Turku Bioscience Centre

Turku Bioscience Centre is an advanced core facility and research centre hosted jointly by University of Turku and Åbo Akademi University.

Our Expertise. Your Discoveries.

Research Services Contacts
NEWS
Registration to FFGC Sequencing day is open!

August 27, 2025

Registration to FFGC Sequencing day is open! The event is organized by Finnish Functional Genomics Centre (FFGC) together with Illumina on Tuesday 16.9.2025  and will Read more

ffgc sequencing

NEWS
Dr. Inna Starskaia at the Turku Bioscience Centre, University of Turku Awarded Prestigious Three-Year Postdoctoral Fellowship

August 22, 2025

Dr. Inna Starskaia has been awarded a prestigious three-year postdoctoral fellowship from Breakthrough T1D, the leading global type 1 diabetes research and advocacy organization. The Read more

All news
EVENT
EVENT
Immunology Seminar, Cecilia Söderberg-Nauclér

September 2, 2025

More Info
Immunology Seminar, Cecilia Söderberg-Nauclér

September 2, 2025

More Info

September 2, 2025 @ 2:00 pm - 3:00 pm - Immunology seminar series is jointly organised by the Finnish Society for Immunology, InFLAMES Flagship and Event details

EVENT
EVENT
Defence: Christel Sourander

September 4, 2025

More Info
Defence: Christel Sourander

September 4, 2025

More Info

September 4, 2025 @ 1:15 pm - 5:00 pm -

All events

10

Core Facilities

Providing cutting-edge biomedical research services through advanced technologies and expert support.

16 + 12

Research & Affiliate Groups

Collaborating across disciplines to drive innovative solutions and breakthrough discoveries.

100+

Publications

Annual publications showcasing impactful scientific contributions in leading international journals.

PUBLICATION

Cholesterol Ester Storage Disease in Two Field Spaniels With Lysosomal Acid Lipase Deficiency 

Pernilla Syrjä et al.

J Vet Intern Med. 2025 Sep-Oct;39(5):e70223. doi: 10.1111/jvim.70223.

Published on August 27, 2025

Cholesterol ester storage disease (CESD) is a rare genetic lysosomal storage disorder resulting from lower lysosomal acid lipase (LAL) activity. LAL is an essential enzyme Read more

PUBLICATION

The impact of conjugation strategies and linker density on the performance of the Spermine-AcDex nanoparticle-splenocyte conjugate 

Yuchen Su et al.

RSC Chem Biol. 2025 Jul 30. doi: 10.1039/d5cb00104h. Online ahead of print.

Published on August 18, 2025

A common approach in living medicine engineering is modifying cell surfaces with nanomedicines to form nanoparticle-cell conjugates. Despite various available strategies, limited research has examined Read more

PUBLICATION

A systematic approach to study the effects of acquisition parameters and biological factors on computerized mammography analysis using ex vivo human tissue: A protocol description 

Nicole Hernández et al.

PLoS One. 2025 Aug 18;20(8):e0321658. doi: 10.1371/journal.pone.0321658. eCollection 2025.

Published on August 18, 2025

BACKGROUND: Mammography is the most common imaging modality for the detection of breast cancer. Artificial intelligence algorithms for mammography analysis have shown promising performance for Read more

PUBLICATION

Detoxification of deoxynivalenol by pathogen-inducible tau-class glutathione transferases from wheat 

Herbert Michlmayr et al.

J Biol Chem. 2025 Aug 14:110600. doi: 10.1016/j.jbc.2025.110600. Online ahead of print.

Published on August 16, 2025

Deoxynivalenol (DON) is a toxicologically relevant trichothecene mycotoxin frequently found in cereal products. It is a virulence factor produced by the plant pathogen Fusarium graminearum Read more

PUBLICATION

Pharmacokinetics, Metabolism, and Toxicity of Anisomelic Acid and Ovatodiolide: Guiding Route of Administration in Preclinical Studies 

Navid Delshad et al.

Eur J Pharm Sci. 2025 Aug 12:107235. doi: 10.1016/j.ejps.2025.107235. Online ahead of print.

Published on August 14, 2025

Despite extensive progress in cancer therapeutic research, translating promising anticancer compounds into clinical treatments often fails due to suboptimal pharmacokinetic and safety profiles. These shortcomings Read more

PUBLICATION

Secreted Clever-1 modulates T cell responses and impacts cancer immunotherapy efficacy 

Stuart Prince et al.

Theranostics. 2025 Jun 23;15(15):7501-7527. doi: 10.7150/thno.110544. eCollection 2025.

Published on August 4, 2025

Rationale: Clever-1 is a multifunctional scavenger receptor that promotes immunosuppressive activity in macrophages, contributing to tumor immune evasion. Its high expression correlates with resistance to Read more

All publications
BLOG
From the Lab to the Stage: My 3MT Experience

May 20, 2025

I had the opportunity to present my PhD research in the finals of the University of Turku 3MT competition. It was a unique and rewarding experience to summarize my work in under three minutes to Read more

BLOG
Grateful to Be a Runner-Up in the University of Turku’s 3MT Competition!

March 10, 2025

I am excited and thankful to have been chosen as a Runner-Up in the Three Minute Thesis (3MT®) competition at the University of Turku on Wednesday, 5 March 2025. This experience has been thrilling, challenging, Read more

BLOG
New method for producing blood stem cells can revolutionize stem cell transplant therapy

November 5, 2024

A new method for producing blood stem cells may in the future replace voluntary bone marrow donors as a source of stem cell transplants. Four European research groups will work on developing the ground-breaking approach Read more

BLOG
New Research Group at TBC: Immune cell navigation

September 24, 2024

Our research aims to understand how immune cells – and especially dendritic cells – navigate and move according to different molecular cues in changing tissue environments.   Gradients of extracellular signaling molecules are a fundamental Read more

All blog posts

"We very much welcome you to contact or visit the Centre if you have a research problem or if you want to access specific technologies or infrastructure services."

Turku Bioscience Centre